 Virginia Ferguson
Concepts (445)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cartilage, Articular | 12 | 2022 | 314 | 3.160 |
Why?
| | Bone and Bones | 12 | 2020 | 300 | 2.580 |
Why?
| | Space Flight | 18 | 2021 | 130 | 2.270 |
Why?
| | Weightlessness | 11 | 2021 | 80 | 2.100 |
Why?
| | Growth Plate | 3 | 2022 | 36 | 1.600 |
Why?
| | Osteocytes | 6 | 2022 | 23 | 1.490 |
Why?
| | Hindlimb Suspension | 8 | 2013 | 24 | 1.340 |
Why?
| | Bone Remodeling | 6 | 2021 | 65 | 1.260 |
Why?
| | Biomechanical Phenomena | 18 | 2020 | 703 | 1.190 |
Why?
| | Finite Element Analysis | 10 | 2019 | 67 | 1.120 |
Why?
| | Collagen | 7 | 2020 | 443 | 1.090 |
Why?
| | Cortical Bone | 4 | 2020 | 19 | 1.070 |
Why?
| | Muscular Atrophy | 5 | 2020 | 86 | 1.070 |
Why?
| | Calcification, Physiologic | 9 | 2020 | 34 | 1.050 |
Why?
| | Bone Diseases, Metabolic | 4 | 2021 | 61 | 1.050 |
Why?
| | Osteoarthritis | 3 | 2016 | 184 | 1.010 |
Why?
| | Cartilage | 4 | 2022 | 191 | 0.970 |
Why?
| | Splenic Artery | 4 | 2016 | 14 | 0.920 |
Why?
| | Glycosaminoglycans | 5 | 2021 | 83 | 0.900 |
Why?
| | Animals | 67 | 2023 | 34345 | 0.890 |
Why?
| | Muscle, Skeletal | 11 | 2020 | 1568 | 0.880 |
Why?
| | Mechanical Phenomena | 4 | 2018 | 83 | 0.870 |
Why?
| | Extracellular Matrix | 5 | 2022 | 462 | 0.870 |
Why?
| | Umbilical Arteries | 2 | 2013 | 41 | 0.830 |
Why?
| | Aging | 6 | 2019 | 1706 | 0.820 |
Why?
| | Mice, Inbred C57BL | 27 | 2021 | 5102 | 0.800 |
Why?
| | Tibia | 9 | 2022 | 182 | 0.790 |
Why?
| | Osteoporosis | 3 | 2020 | 243 | 0.760 |
Why?
| | Hydrogels | 8 | 2022 | 608 | 0.750 |
Why?
| | Elasticity | 8 | 2017 | 191 | 0.750 |
Why?
| | Renal Insufficiency, Chronic | 2 | 2019 | 612 | 0.750 |
Why?
| | Femur | 11 | 2021 | 204 | 0.700 |
Why?
| | Bone Density | 14 | 2022 | 459 | 0.690 |
Why?
| | Sepharose | 2 | 2017 | 33 | 0.690 |
Why?
| | Hindlimb | 4 | 2021 | 137 | 0.680 |
Why?
| | Fetal Growth Retardation | 3 | 2013 | 477 | 0.680 |
Why?
| | Fractures, Bone | 3 | 2021 | 390 | 0.630 |
Why?
| | Physical Conditioning, Animal | 3 | 2010 | 209 | 0.630 |
Why?
| | Polyethylene Glycols | 6 | 2022 | 577 | 0.620 |
Why?
| | Vascular Stiffness | 2 | 2013 | 431 | 0.620 |
Why?
| | Tissue Engineering | 7 | 2022 | 379 | 0.610 |
Why?
| | Mice | 38 | 2023 | 15984 | 0.590 |
Why?
| | Tissue Scaffolds | 3 | 2021 | 198 | 0.590 |
Why?
| | Models, Theoretical | 2 | 2017 | 585 | 0.530 |
Why?
| | Muscle Strength | 3 | 2020 | 294 | 0.530 |
Why?
| | Macrophage Colony-Stimulating Factor | 3 | 2011 | 18 | 0.520 |
Why?
| | Cancellous Bone | 4 | 2020 | 22 | 0.510 |
Why?
| | Cervix Uteri | 1 | 2015 | 49 | 0.490 |
Why?
| | Water | 2 | 2016 | 432 | 0.490 |
Why?
| | Carotid Arteries | 2 | 2013 | 190 | 0.470 |
Why?
| | Chondrocytes | 1 | 2016 | 212 | 0.460 |
Why?
| | Stress, Mechanical | 7 | 2022 | 456 | 0.460 |
Why?
| | Insulin-Like Growth Factor I | 3 | 2013 | 303 | 0.450 |
Why?
| | Aorta, Abdominal | 1 | 2013 | 44 | 0.450 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 743 | 0.440 |
Why?
| | Software | 1 | 2018 | 647 | 0.430 |
Why?
| | Muscle Fatigue | 2 | 2013 | 97 | 0.430 |
Why?
| | Intervertebral Disc | 1 | 2013 | 34 | 0.430 |
Why?
| | Adaptation, Biological | 1 | 2013 | 57 | 0.430 |
Why?
| | Tooth Wear | 1 | 2012 | 18 | 0.410 |
Why?
| | Dental Enamel | 1 | 2012 | 64 | 0.400 |
Why?
| | Neurophysiology | 1 | 2012 | 16 | 0.400 |
Why?
| | Anisotropy | 3 | 2016 | 68 | 0.400 |
Why?
| | Lemur | 1 | 2012 | 51 | 0.400 |
Why?
| | Lumbar Vertebrae | 1 | 2013 | 218 | 0.390 |
Why?
| | Horses | 2 | 2009 | 110 | 0.380 |
Why?
| | Haversian System | 1 | 2010 | 2 | 0.370 |
Why?
| | Aorta, Thoracic | 1 | 2013 | 284 | 0.370 |
Why?
| | Cartilage Diseases | 2 | 2019 | 47 | 0.360 |
Why?
| | Swine | 7 | 2019 | 786 | 0.360 |
Why?
| | Pre-Eclampsia | 1 | 2013 | 191 | 0.360 |
Why?
| | Porosity | 3 | 2020 | 90 | 0.340 |
Why?
| | Bone Development | 4 | 2004 | 56 | 0.330 |
Why?
| | Electric Stimulation | 2 | 2013 | 276 | 0.330 |
Why?
| | Gene Expression Regulation | 6 | 2019 | 2492 | 0.330 |
Why?
| | Spleen | 5 | 2017 | 513 | 0.330 |
Why?
| | Umbilical Cord | 1 | 2009 | 82 | 0.320 |
Why?
| | Metacarpal Bones | 1 | 2008 | 13 | 0.320 |
Why?
| | Regenerative Medicine | 2 | 2019 | 46 | 0.310 |
Why?
| | Female | 38 | 2023 | 64890 | 0.300 |
Why?
| | X-Ray Microtomography | 3 | 2019 | 75 | 0.290 |
Why?
| | Osteoblasts | 4 | 2020 | 118 | 0.290 |
Why?
| | Male | 29 | 2021 | 60793 | 0.290 |
Why?
| | Bone Diseases | 2 | 2018 | 61 | 0.290 |
Why?
| | Exercise Test | 2 | 2013 | 585 | 0.290 |
Why?
| | Osteogenesis | 2 | 2019 | 223 | 0.280 |
Why?
| | Compressive Strength | 3 | 2019 | 69 | 0.280 |
Why?
| | Thymus Gland | 4 | 2013 | 301 | 0.280 |
Why?
| | Recovery of Function | 1 | 2010 | 620 | 0.270 |
Why?
| | Cattle | 3 | 2022 | 1010 | 0.270 |
Why?
| | Range of Motion, Articular | 1 | 2008 | 379 | 0.270 |
Why?
| | Tensile Strength | 3 | 2015 | 101 | 0.260 |
Why?
| | Phantoms, Imaging | 2 | 2018 | 158 | 0.260 |
Why?
| | Elastic Modulus | 3 | 2016 | 116 | 0.260 |
Why?
| | Arteries | 3 | 2018 | 257 | 0.260 |
Why?
| | Microscopy, Confocal | 2 | 2018 | 317 | 0.250 |
Why?
| | Materials Testing | 4 | 2016 | 350 | 0.250 |
Why?
| | Elasticity Imaging Techniques | 2 | 2016 | 46 | 0.250 |
Why?
| | Models, Biological | 4 | 2016 | 1753 | 0.240 |
Why?
| | Rabbits | 3 | 2022 | 795 | 0.240 |
Why?
| | Pregnancy | 6 | 2015 | 5922 | 0.240 |
Why?
| | Imaging, Three-Dimensional | 2 | 2019 | 554 | 0.240 |
Why?
| | Printing, Three-Dimensional | 3 | 2022 | 69 | 0.240 |
Why?
| | Neurons | 1 | 2012 | 1365 | 0.230 |
Why?
| | Algorithms | 3 | 2018 | 1618 | 0.230 |
Why?
| | Body Composition | 2 | 2021 | 679 | 0.220 |
Why?
| | Femur Head | 1 | 2003 | 44 | 0.220 |
Why?
| | Models, Cardiovascular | 2 | 2016 | 190 | 0.220 |
Why?
| | Physical Examination | 1 | 2005 | 256 | 0.220 |
Why?
| | Osteoclasts | 2 | 2020 | 36 | 0.220 |
Why?
| | Temperature | 2 | 2018 | 635 | 0.220 |
Why?
| | Elastin | 2 | 2013 | 78 | 0.210 |
Why?
| | Computer Simulation | 3 | 2016 | 953 | 0.210 |
Why?
| | Pelvic Floor | 1 | 2023 | 27 | 0.210 |
Why?
| | Pelvic Organ Prolapse | 1 | 2023 | 40 | 0.210 |
Why?
| | Bone Resorption | 3 | 2015 | 85 | 0.210 |
Why?
| | Disease Models, Animal | 8 | 2019 | 3823 | 0.200 |
Why?
| | Sheep | 3 | 2013 | 768 | 0.200 |
Why?
| | Stereolithography | 2 | 2021 | 11 | 0.200 |
Why?
| | Esters | 1 | 2022 | 61 | 0.200 |
Why?
| | Dinoprostone | 1 | 2022 | 195 | 0.200 |
Why?
| | Pressure | 4 | 2015 | 237 | 0.190 |
Why?
| | Sialoglycoproteins | 1 | 2002 | 162 | 0.190 |
Why?
| | Biomimetics | 1 | 2021 | 43 | 0.190 |
Why?
| | Humans | 32 | 2022 | 125132 | 0.190 |
Why?
| | Glycation End Products, Advanced | 1 | 2021 | 72 | 0.180 |
Why?
| | Exercise Therapy | 1 | 2005 | 387 | 0.180 |
Why?
| | Second Harmonic Generation Microscopy | 1 | 2020 | 3 | 0.180 |
Why?
| | Nursing Care | 1 | 2001 | 34 | 0.180 |
Why?
| | Myosin Heavy Chains | 2 | 2013 | 193 | 0.180 |
Why?
| | Quantitative Trait Loci | 1 | 2022 | 349 | 0.180 |
Why?
| | Calcinosis | 1 | 2003 | 304 | 0.180 |
Why?
| | Multiple Myeloma | 1 | 2002 | 108 | 0.180 |
Why?
| | Bone Matrix | 2 | 2019 | 11 | 0.180 |
Why?
| | United States National Aeronautics and Space Administration | 1 | 2020 | 4 | 0.180 |
Why?
| | Hardness Tests | 2 | 2010 | 2 | 0.180 |
Why?
| | Weightlessness Simulation | 1 | 2020 | 13 | 0.180 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2015 | 202 | 0.180 |
Why?
| | Myostatin | 1 | 2020 | 26 | 0.180 |
Why?
| | Spectrum Analysis, Raman | 1 | 2020 | 48 | 0.170 |
Why?
| | Aerospace Medicine | 1 | 2020 | 23 | 0.170 |
Why?
| | Salter-Harris Fractures | 1 | 2019 | 13 | 0.170 |
Why?
| | Organ Size | 5 | 2013 | 479 | 0.170 |
Why?
| | Fracture Healing | 1 | 2020 | 78 | 0.170 |
Why?
| | Scattering, Small Angle | 1 | 2019 | 21 | 0.170 |
Why?
| | Liver | 3 | 2017 | 1872 | 0.170 |
Why?
| | Oxidative Stress | 4 | 2018 | 1210 | 0.170 |
Why?
| | Disease Progression | 2 | 2016 | 2577 | 0.160 |
Why?
| | Ligation | 2 | 2016 | 82 | 0.160 |
Why?
| | X-Ray Diffraction | 1 | 2019 | 88 | 0.160 |
Why?
| | Body Weight | 5 | 2016 | 960 | 0.150 |
Why?
| | Reproducibility of Results | 2 | 2019 | 3047 | 0.150 |
Why?
| | Polymers | 1 | 2022 | 476 | 0.150 |
Why?
| | Lipid Bilayers | 1 | 2019 | 102 | 0.150 |
Why?
| | Osteoarthritis, Knee | 1 | 2021 | 229 | 0.150 |
Why?
| | Knee Joint | 1 | 2021 | 365 | 0.150 |
Why?
| | Physical Exertion | 2 | 2012 | 236 | 0.150 |
Why?
| | Gene Expression | 4 | 2022 | 1528 | 0.140 |
Why?
| | Adrenal Glands | 1 | 2017 | 76 | 0.140 |
Why?
| | Osteoprotegerin | 2 | 2015 | 23 | 0.140 |
Why?
| | Actins | 4 | 2020 | 410 | 0.140 |
Why?
| | Rats | 5 | 2021 | 5517 | 0.140 |
Why?
| | Regression Analysis | 1 | 2019 | 1047 | 0.130 |
Why?
| | Diffusion | 1 | 2016 | 129 | 0.130 |
Why?
| | Permeability | 1 | 2016 | 155 | 0.130 |
Why?
| | Sex Characteristics | 1 | 2021 | 699 | 0.130 |
Why?
| | Energy Intake | 1 | 1999 | 463 | 0.130 |
Why?
| | Femoral Neck Fractures | 1 | 2016 | 26 | 0.130 |
Why?
| | Genome-Wide Association Study | 1 | 2022 | 1403 | 0.130 |
Why?
| | Kidney Function Tests | 1 | 2016 | 164 | 0.130 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2015 | 35 | 0.130 |
Why?
| | Weight-Bearing | 3 | 2021 | 171 | 0.130 |
Why?
| | Hemostatic Techniques | 1 | 2015 | 41 | 0.130 |
Why?
| | Wound Healing | 1 | 2017 | 298 | 0.130 |
Why?
| | Tissue Preservation | 1 | 2014 | 14 | 0.120 |
Why?
| | Muscle Contraction | 2 | 2010 | 421 | 0.120 |
Why?
| | Environment | 2 | 2014 | 355 | 0.120 |
Why?
| | Biocompatible Materials | 2 | 2016 | 389 | 0.120 |
Why?
| | Veins | 1 | 2014 | 63 | 0.120 |
Why?
| | Phenotype | 2 | 2021 | 3153 | 0.120 |
Why?
| | Models, Anatomic | 1 | 2014 | 95 | 0.110 |
Why?
| | Surface Properties | 3 | 2012 | 411 | 0.110 |
Why?
| | SKP Cullin F-Box Protein Ligases | 1 | 2013 | 12 | 0.110 |
Why?
| | Tripartite Motif Proteins | 1 | 2013 | 31 | 0.110 |
Why?
| | Thermometry | 1 | 2013 | 2 | 0.110 |
Why?
| | Electrocoagulation | 1 | 2013 | 38 | 0.110 |
Why?
| | Neurogenesis | 1 | 2014 | 105 | 0.110 |
Why?
| | Proteomics | 1 | 2018 | 903 | 0.110 |
Why?
| | Compliance | 1 | 2012 | 43 | 0.110 |
Why?
| | Internet | 1 | 2018 | 700 | 0.100 |
Why?
| | Vascular Surgical Procedures | 1 | 2015 | 277 | 0.100 |
Why?
| | Eye | 1 | 2013 | 108 | 0.100 |
Why?
| | Tooth Calcification | 1 | 2012 | 3 | 0.100 |
Why?
| | Recombinant Fusion Proteins | 1 | 2015 | 658 | 0.100 |
Why?
| | Anthropology, Physical | 1 | 2012 | 29 | 0.100 |
Why?
| | Madagascar | 1 | 2012 | 40 | 0.100 |
Why?
| | Olfactory Bulb | 1 | 2014 | 125 | 0.100 |
Why?
| | Cell Death | 1 | 2014 | 347 | 0.100 |
Why?
| | Molar | 1 | 2012 | 53 | 0.100 |
Why?
| | Catheter Ablation | 1 | 2015 | 325 | 0.100 |
Why?
| | Mitochondria | 2 | 2018 | 823 | 0.100 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2013 | 162 | 0.100 |
Why?
| | Reflex | 1 | 2012 | 70 | 0.100 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2013 | 198 | 0.100 |
Why?
| | Microscopy, Atomic Force | 1 | 2012 | 119 | 0.100 |
Why?
| | Hepatitis A | 4 | 1982 | 28 | 0.100 |
Why?
| | Muscle Proteins | 1 | 2013 | 224 | 0.100 |
Why?
| | Placental Insufficiency | 1 | 2013 | 104 | 0.100 |
Why?
| | Cell Differentiation | 5 | 2020 | 1778 | 0.100 |
Why?
| | Viscoelastic Substances | 1 | 2011 | 9 | 0.100 |
Why?
| | Case-Control Studies | 2 | 2013 | 3326 | 0.100 |
Why?
| | Ecology | 1 | 2012 | 108 | 0.100 |
Why?
| | Primates | 1 | 2012 | 114 | 0.100 |
Why?
| | Video Recording | 1 | 2012 | 169 | 0.090 |
Why?
| | Stress, Physiological | 2 | 2015 | 429 | 0.090 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2013 | 532 | 0.090 |
Why?
| | Polymethyl Methacrylate | 1 | 2010 | 21 | 0.090 |
Why?
| | Plastics | 1 | 2010 | 40 | 0.090 |
Why?
| | Electromagnetic Fields | 1 | 2010 | 22 | 0.090 |
Why?
| | Reaction Time | 1 | 2012 | 411 | 0.090 |
Why?
| | Radiography | 2 | 2011 | 893 | 0.090 |
Why?
| | Action Potentials | 1 | 2013 | 434 | 0.090 |
Why?
| | Middle Aged | 6 | 2020 | 29112 | 0.090 |
Why?
| | Data Interpretation, Statistical | 1 | 2012 | 344 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2013 | 1366 | 0.090 |
Why?
| | Cell Proliferation | 3 | 2012 | 2333 | 0.090 |
Why?
| | Time Factors | 6 | 2013 | 6780 | 0.090 |
Why?
| | Gene Expression Profiling | 5 | 2017 | 1642 | 0.090 |
Why?
| | Gestational Age | 1 | 2012 | 797 | 0.080 |
Why?
| | Skin | 1 | 2014 | 698 | 0.080 |
Why?
| | Myoglobin | 1 | 2009 | 15 | 0.080 |
Why?
| | Receptors, Glucocorticoid | 1 | 2010 | 136 | 0.080 |
Why?
| | Granulocytes | 1 | 2008 | 81 | 0.080 |
Why?
| | Viscosity | 1 | 2009 | 91 | 0.080 |
Why?
| | Endothelial Cells | 2 | 2013 | 742 | 0.080 |
Why?
| | Fetus | 1 | 2013 | 713 | 0.080 |
Why?
| | Transcriptome | 3 | 2022 | 801 | 0.080 |
Why?
| | Immunity | 1 | 2009 | 130 | 0.080 |
Why?
| | Interleukin-6 | 2 | 2022 | 710 | 0.080 |
Why?
| | Mice, Inbred BALB C | 2 | 2020 | 1233 | 0.080 |
Why?
| | Lymphocyte Activation | 2 | 2009 | 1077 | 0.080 |
Why?
| | Aged, 80 and over | 2 | 2013 | 6936 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2236 | 0.070 |
Why?
| | Nanotechnology | 1 | 2009 | 121 | 0.070 |
Why?
| | Bone Marrow Cells | 1 | 2008 | 276 | 0.070 |
Why?
| | Sulfhydryl Compounds | 2 | 2022 | 191 | 0.070 |
Why?
| | Models, Animal | 2 | 2021 | 373 | 0.070 |
Why?
| | Infant | 8 | 2017 | 8625 | 0.070 |
Why?
| | Regional Blood Flow | 1 | 2009 | 441 | 0.070 |
Why?
| | Metabolomics | 3 | 2017 | 551 | 0.070 |
Why?
| | Brain | 1 | 2018 | 2639 | 0.070 |
Why?
| | Longitudinal Studies | 1 | 2013 | 2669 | 0.070 |
Why?
| | Apoptosis | 1 | 2015 | 2553 | 0.060 |
Why?
| | Body Mass Index | 1 | 2013 | 2174 | 0.060 |
Why?
| | Muscular Disorders, Atrophic | 1 | 2005 | 3 | 0.060 |
Why?
| | Metabolome | 2 | 2018 | 307 | 0.060 |
Why?
| | Systems Integration | 1 | 2005 | 42 | 0.060 |
Why?
| | Men | 1 | 2005 | 21 | 0.060 |
Why?
| | Cell Survival | 3 | 2017 | 1081 | 0.060 |
Why?
| | Sciatic Nerve | 1 | 2005 | 59 | 0.060 |
Why?
| | Hepatitis B | 4 | 1982 | 55 | 0.060 |
Why?
| | Infant, Newborn | 5 | 2013 | 5456 | 0.060 |
Why?
| | Adult | 9 | 2013 | 33168 | 0.060 |
Why?
| | Pregnancy Complications | 1 | 2009 | 464 | 0.060 |
Why?
| | Cytokines | 2 | 2009 | 1927 | 0.060 |
Why?
| | Diaphyses | 1 | 2003 | 15 | 0.060 |
Why?
| | Hypertension | 1 | 2012 | 1257 | 0.060 |
Why?
| | Endothelium, Vascular | 1 | 2010 | 919 | 0.060 |
Why?
| | Fascia | 1 | 2023 | 17 | 0.050 |
Why?
| | United States | 1 | 2020 | 13613 | 0.050 |
Why?
| | In Vitro Techniques | 2 | 2015 | 1144 | 0.050 |
Why?
| | Adolescent | 9 | 2017 | 19411 | 0.050 |
Why?
| | Ligaments | 1 | 2023 | 48 | 0.050 |
Why?
| | Polystyrenes | 1 | 2022 | 34 | 0.050 |
Why?
| | Lung | 1 | 2015 | 3865 | 0.050 |
Why?
| | Biomarkers | 4 | 2016 | 3736 | 0.050 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2018 | 3471 | 0.050 |
Why?
| | Equipment Design | 2 | 2014 | 545 | 0.050 |
Why?
| | Myocardium | 2 | 1997 | 992 | 0.050 |
Why?
| | Uterus | 1 | 2023 | 197 | 0.050 |
Why?
| | Genes, MHC Class II | 1 | 2002 | 73 | 0.050 |
Why?
| | RNA, Messenger | 5 | 2016 | 2753 | 0.050 |
Why?
| | Meniscus | 1 | 2021 | 22 | 0.050 |
Why?
| | Chondrogenesis | 1 | 2021 | 84 | 0.050 |
Why?
| | T-Lymphocytes | 1 | 2008 | 1793 | 0.050 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 256 | 0.050 |
Why?
| | Guanidinoacetate N-Methyltransferase | 1 | 2020 | 5 | 0.040 |
Why?
| | Biophysics | 1 | 2020 | 74 | 0.040 |
Why?
| | Corticosterone | 2 | 2017 | 257 | 0.040 |
Why?
| | Cell Culture Techniques | 1 | 2022 | 356 | 0.040 |
Why?
| | International Cooperation | 1 | 2001 | 187 | 0.040 |
Why?
| | Hyaluronic Acid | 1 | 2002 | 201 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2021 | 409 | 0.040 |
Why?
| | Protein Isoforms | 1 | 2001 | 354 | 0.040 |
Why?
| | Dietary Sucrose | 1 | 2000 | 55 | 0.040 |
Why?
| | Hydrostatic Pressure | 1 | 2019 | 21 | 0.040 |
Why?
| | Durapatite | 1 | 1999 | 55 | 0.040 |
Why?
| | Osseointegration | 1 | 1999 | 40 | 0.040 |
Why?
| | Bone Substitutes | 1 | 1999 | 47 | 0.040 |
Why?
| | Extremities | 1 | 2020 | 116 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2021 | 251 | 0.040 |
Why?
| | Lymphocyte Count | 2 | 2009 | 140 | 0.040 |
Why?
| | Humerus | 1 | 1998 | 42 | 0.040 |
Why?
| | Signal Transduction | 3 | 2018 | 4809 | 0.040 |
Why?
| | Forecasting | 1 | 2001 | 379 | 0.040 |
Why?
| | Proteoglycans | 1 | 2019 | 112 | 0.040 |
Why?
| | Intracellular Space | 1 | 2018 | 72 | 0.040 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 199 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 168 | 0.040 |
Why?
| | Interprofessional Relations | 1 | 2001 | 282 | 0.040 |
Why?
| | Gray Matter | 1 | 2018 | 66 | 0.040 |
Why?
| | Glycoproteins | 1 | 2000 | 330 | 0.040 |
Why?
| | Femur Neck | 1 | 2018 | 66 | 0.040 |
Why?
| | Cell Cycle | 1 | 2001 | 578 | 0.040 |
Why?
| | Receptors, Corticotropin | 1 | 2017 | 2 | 0.040 |
Why?
| | Dietary Fats | 1 | 2000 | 332 | 0.040 |
Why?
| | Sarcomeres | 1 | 1997 | 93 | 0.040 |
Why?
| | Glycolysis | 1 | 2018 | 241 | 0.040 |
Why?
| | Young Adult | 1 | 2013 | 11385 | 0.040 |
Why?
| | Osteoporotic Fractures | 1 | 2018 | 61 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2002 | 984 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2010 | 785 | 0.040 |
Why?
| | Immune System Diseases | 1 | 2017 | 36 | 0.040 |
Why?
| | Polymerization | 1 | 2017 | 129 | 0.040 |
Why?
| | Catecholamines | 1 | 2017 | 106 | 0.040 |
Why?
| | White Matter | 1 | 2018 | 124 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2848 | 0.030 |
Why?
| | Diabetes Complications | 1 | 2018 | 231 | 0.030 |
Why?
| | Hepatic Stellate Cells | 1 | 2016 | 11 | 0.030 |
Why?
| | Lipid Droplets | 1 | 2016 | 21 | 0.030 |
Why?
| | PPAR alpha | 1 | 2016 | 56 | 0.030 |
Why?
| | Adhesiveness | 1 | 2015 | 19 | 0.030 |
Why?
| | Click Chemistry | 1 | 2016 | 52 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2020 | 808 | 0.030 |
Why?
| | Metabolic Diseases | 1 | 2017 | 109 | 0.030 |
Why?
| | Leukocytes | 1 | 2017 | 292 | 0.030 |
Why?
| | Systems Biology | 1 | 2016 | 60 | 0.030 |
Why?
| | RANK Ligand | 1 | 2015 | 28 | 0.030 |
Why?
| | Osteocalcin | 1 | 2015 | 36 | 0.030 |
Why?
| | Phagocytosis | 1 | 2017 | 364 | 0.030 |
Why?
| | Light | 1 | 2017 | 346 | 0.030 |
Why?
| | Flow Cytometry | 2 | 2008 | 1108 | 0.030 |
Why?
| | DNA Primers | 2 | 2010 | 545 | 0.030 |
Why?
| | Bone Density Conservation Agents | 1 | 2015 | 63 | 0.030 |
Why?
| | Alkaline Phosphatase | 1 | 2015 | 160 | 0.030 |
Why?
| | Surgical Equipment | 1 | 2014 | 13 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 593 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2015 | 182 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2015 | 455 | 0.030 |
Why?
| | DNA Fragmentation | 1 | 2013 | 50 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2022 | 2382 | 0.030 |
Why?
| | Shear Strength | 1 | 2013 | 66 | 0.030 |
Why?
| | Child, Preschool | 7 | 2017 | 9938 | 0.030 |
Why?
| | Oncogene Proteins | 1 | 2013 | 53 | 0.030 |
Why?
| | Electric Impedance | 1 | 2013 | 105 | 0.030 |
Why?
| | Adaptation, Physiological | 2 | 2008 | 517 | 0.030 |
Why?
| | Hyalin | 1 | 2012 | 6 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 1997 | 836 | 0.030 |
Why?
| | Base Sequence | 2 | 2010 | 2207 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2009 | 2026 | 0.030 |
Why?
| | Hepatitis, Viral, Human | 2 | 1982 | 27 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 1997 | 1376 | 0.020 |
Why?
| | Stem Cells | 1 | 2015 | 570 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2005 | 9790 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2013 | 943 | 0.020 |
Why?
| | Umbilical Veins | 1 | 2010 | 60 | 0.020 |
Why?
| | Molecular Structure | 1 | 2011 | 470 | 0.020 |
Why?
| | Fluorescent Antibody Technique, Indirect | 2 | 2001 | 55 | 0.020 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2010 | 198 | 0.020 |
Why?
| | Hemoglobin H | 1 | 1989 | 1 | 0.020 |
Why?
| | Thalassemia | 1 | 1989 | 7 | 0.020 |
Why?
| | Hemoglobins, Abnormal | 1 | 1989 | 10 | 0.020 |
Why?
| | Aged | 4 | 2003 | 20859 | 0.020 |
Why?
| | Antibodies, Viral | 3 | 1982 | 561 | 0.020 |
Why?
| | Antigens, Ly | 1 | 2008 | 47 | 0.020 |
Why?
| | CD11b Antigen | 1 | 2008 | 58 | 0.020 |
Why?
| | Antigens, Differentiation | 1 | 2008 | 79 | 0.020 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2008 | 61 | 0.020 |
Why?
| | Hyaluronan Receptors | 1 | 2008 | 95 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2009 | 315 | 0.020 |
Why?
| | Child | 7 | 2017 | 20014 | 0.020 |
Why?
| | Cell Count | 1 | 2008 | 321 | 0.020 |
Why?
| | Feeding Behavior | 1 | 2013 | 618 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2008 | 286 | 0.020 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2008 | 131 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2008 | 199 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1008 | 0.020 |
Why?
| | Obesity | 1 | 2021 | 2805 | 0.020 |
Why?
| | Genetic Markers | 1 | 1989 | 368 | 0.020 |
Why?
| | Epidemiologic Methods | 3 | 1982 | 74 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2010 | 537 | 0.020 |
Why?
| | DNA Replication | 1 | 2008 | 218 | 0.020 |
Why?
| | Microscopy, Fluorescence | 2 | 2001 | 419 | 0.020 |
Why?
| | Cell Lineage | 1 | 2008 | 322 | 0.020 |
Why?
| | Radiation Dosage | 1 | 2008 | 152 | 0.020 |
Why?
| | Hepatitis B Surface Antigens | 3 | 1982 | 19 | 0.020 |
Why?
| | Transfection | 2 | 2001 | 923 | 0.020 |
Why?
| | Blood Pressure | 1 | 2013 | 1735 | 0.020 |
Why?
| | Australia | 3 | 1982 | 228 | 0.020 |
Why?
| | Killer Cells, Natural | 1 | 2008 | 389 | 0.020 |
Why?
| | Up-Regulation | 1 | 2009 | 895 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 870 | 0.020 |
Why?
| | Nerve Compression Syndromes | 1 | 2005 | 29 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2010 | 886 | 0.020 |
Why?
| | Risk Factors | 1 | 2018 | 9549 | 0.010 |
Why?
| | Pilot Projects | 1 | 2009 | 1530 | 0.010 |
Why?
| | Hepatovirus | 2 | 1982 | 3 | 0.010 |
Why?
| | Hepatitis B Core Antigens | 2 | 1981 | 5 | 0.010 |
Why?
| | Hepatitis B Antibodies | 2 | 1981 | 10 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 2 | 2000 | 2512 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2008 | 781 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1196 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2010 | 4159 | 0.010 |
Why?
| | Cell Line | 1 | 2008 | 2806 | 0.010 |
Why?
| | Papua New Guinea | 1 | 1981 | 8 | 0.010 |
Why?
| | MyoD Protein | 1 | 2001 | 29 | 0.010 |
Why?
| | Altitude | 2 | 1981 | 461 | 0.010 |
Why?
| | Maxillofacial Prosthesis Implantation | 1 | 1999 | 3 | 0.010 |
Why?
| | Placebos | 1 | 2000 | 208 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2000 | 148 | 0.010 |
Why?
| | Antigens, Viral | 1 | 1980 | 182 | 0.010 |
Why?
| | Disease Outbreaks | 1 | 1982 | 334 | 0.010 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 1998 | 65 | 0.010 |
Why?
| | Myosin Light Chains | 1 | 1997 | 35 | 0.010 |
Why?
| | Troponin | 1 | 1997 | 50 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 1997 | 146 | 0.010 |
Why?
| | Troponin T | 1 | 1997 | 50 | 0.010 |
Why?
| | Mice, Inbred DBA | 1 | 1997 | 185 | 0.010 |
Why?
| | Tropomyosin | 1 | 1997 | 13 | 0.010 |
Why?
| | Muscle Development | 1 | 1997 | 103 | 0.010 |
Why?
| | Molecular Weight | 1 | 1997 | 345 | 0.010 |
Why?
| | Cell Movement | 1 | 2001 | 913 | 0.010 |
Why?
| | Age Factors | 2 | 1981 | 3152 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1997 | 830 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2002 | 2736 | 0.010 |
Why?
| | Heart | 1 | 1997 | 668 | 0.010 |
Why?
| | Prospective Studies | 2 | 1981 | 6818 | 0.010 |
Why?
| | Hepatitis C | 2 | 1982 | 239 | 0.010 |
Why?
| | Radioimmunoassay | 1 | 1982 | 170 | 0.000 |
Why?
| | New Guinea | 1 | 1981 | 4 | 0.000 |
Why?
| | Immunoglobulins | 1 | 1982 | 155 | 0.000 |
Why?
| | Injections | 1 | 1982 | 171 | 0.000 |
Why?
| | Family Health | 1 | 1982 | 209 | 0.000 |
Why?
| | Immunoglobulin M | 1 | 1982 | 253 | 0.000 |
Why?
| | Follow-Up Studies | 1 | 1982 | 4824 | 0.000 |
Why?
|
|
Ferguson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|